Clinical Trials

Phase 2 Active not recruiting

1,455 enrolled

Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT01898494 2026-04-01

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

519 enrolled 16 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT06256718 2026-03-17

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

203 enrolled

Papillomavirus Infections

NCT00867464 2026-03-03

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

GastrointestinalGynecologicHead & Neck

8,670 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Mouth Neoplasms, Papillomavirus Infections

NCT05883111 2026-02-19

Self-TI

Phase 1/2 Active not recruiting

100 enrolled

Papillomavirus Infections

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

141 enrolled

Sexually Transmitted Diseases, Papillomavirus Infections

NCT04206813 2026-01-27

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

352 enrolled

Papillomavirus Infections

NCT02897427 2026-01-26

TRINITY

1,500 enrolled

Papillomavirus Infections

NCT03309033 2026-01-23

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

991 enrolled

Papillomavirus Infections

NCT04255849 2026-01-23

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

700 enrolled

Papillomavirus Infections

NCT06632912 2026-01-23

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

1,800 enrolled

Infections, Papillomavirus Infections

NCT05057312 2026-01-21

Promoting HPV Vaccination Among Young Adults in Texas

1,200 enrolled

Papillomavirus Infections

NCT06302725 2026-01-15

APOSY

300 enrolled

Papillomavirus Infections

NCT01901770 2026-01-12

PARENT

624 enrolled

Papillomavirus Infections

NCT04124198 2025-12-31

QoLATI

138 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Papillomavirus Infections

NCT06611540 2025-12-30

LMI-001-A-S03

500 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2025-12-15

LMI-001-A-S02

500 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06162676 2025-12-03

Game-Based Intervention to Promote HPV Vaccination

131 enrolled

Vaccine-Preventable Diseases, Papillomavirus Infections

NCT06002126 2025-11-14

ULACNet-202

1,002 enrolled

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT06577220 2025-10-14

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

111 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04953130 2025-09-10

Add-Vacc

10,400 enrolled

Vaccine-Preventable Diseases, Papillomavirus Infections

NCT03180034 2025-09-04

ESCUDDO

27,945 enrolled

Papillomavirus Infections

NCT02816879 2025-07-29

Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men

415 enrolled

Gastrointestinal

Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT06120205 2025-07-18

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

870 enrolled

Papillomavirus Infections

NCT04965792 2025-06-17

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

Phase 1/2 Active not recruiting

150 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT04724980 2025-06-11

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

38 enrolled

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT05555862 2025-05-18

anal HSIL HIV-

Phase 2 Active not recruiting

17 enrolled

Papillomavirus Infections

NCT06959563 2025-05-13

9vHPV-BCG

Phase EARLY_PHASE1 Active not recruiting

20 enrolled

Papillomavirus Infections

NCT04708041 2025-04-20

V503-069

700 enrolled

Papillomavirus Infections

NCT06452004 2025-04-04

AI-DSS

600 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04235257 2025-03-27

Intradermal, Fractional Dose of HPV Vaccines:

40 enrolled

Papillomavirus Infections

NCT05291871 2025-03-27

Immunogenicity of Fractional Dose of the HPV Vaccines

92 enrolled

Papillomavirus Infections

NCT04199689 2025-03-25

V503-049

6,033 enrolled

Papillomavirus Infections

NCT06776055 2025-01-15

Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women

5,372 enrolled

Phase 1 Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT06454175 2025-01-06

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

72 enrolled

Condylomata Acuminata, Papillomavirus Infections

NCT05285826 2024-12-16

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

8,100 enrolled

Papillomavirus Infections

NCT02653118 2024-11-12

Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)

4,453 enrolled

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05003505 2024-09-19

Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection

651 enrolled

Papillomavirus Infections

NCT04270773 2024-07-10

9-VPH-MVIH

158 enrolled

HIV Infections, Papillomavirus Infections

NCT00892866 2024-05-03

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

877 enrolled

Uterine Cervical Dysplasia, Endometrial Hyperplasia, Papillomavirus Infections

NCT05613283 2023-12-21

PREVENT

17,875 enrolled

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix, Adenocarcinoma in Situ

NCT06041061 2023-09-18

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

18,000 enrolled

Papillomavirus Infections

NCT05662020 2022-12-27

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

GastrointestinalGynecologic

2,750 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT03998254 2022-11-16

V503-023

6,000 enrolled

Papillomavirus Infections

NCT05450705 2022-09-02

V503-071